M.A.G.I.C. Clinic Ltd.

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Fabry disease2 trials

Phase

• Phase 1/21 trial
• Phase 21 trial

Status

• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• Sangamo Therapeutics2 trials

Running trials

• Active, not recruiting

  Long-Term Follow-up of Subjects Who Were Treated With ST-920

  NCT05039866· Phase 2· Sangamo Therapeutics· Source

Closed trials

• Completed

  Dose-Ranging Study of ST-920, an AAV2/6 Human Alpha Galactosidase A Gene Therapy in Subjects With Fabry Disease (STAAR)

  NCT04046224· Phase 1/2· Sangamo Therapeutics· Source